Marshall Douglas Brinkley MD
Heart Failure & Transplantation
Assistant Professor of Medicine
Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-2318
Fax+1 615-343-4841
Dr. Brinkley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Marshall Brinkley is a cardiologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Advanced Heart Failure and Transplant Cardiology, 2015 - 2016
Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 2012 - 2015
Harvard School of Public HealthCertificate, Program in Clinical Effectiveness, 2014
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2007 - 2010
Vanderbilt University School of MedicineClass of 2007- Duke UniversityB.S., Biology & Chemistry, 1998 - 2002
Certifications & Licensure
TN State Medical License 2016 - 2026
AL State Medical License 2020 - 2020
MA State Medical License 2013 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Chief Fellow Beth Israel Deaconess Medical Center, 2014
- Clinical Scientist Training Washington University, 2009
- Magna cum laude Duke University, 2002
- Join now to see all
Clinical Trials
- A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) Start of enrollment: 2016 Sep 20
- Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction Start of enrollment: 2017 Jan 06
- A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035) Start of enrollment: 2021 Nov 02
- Join now to see all
Publications & Presentations
PubMed
- The Safety and Late Hemodynamics of Donor Cardiac Undersizing in Heart Transplantation.Chetan Pasrija, Alexandra Debose-Scarlett, Daniel K Ragheb, Hasan K Siddiqi, Kaushik Amancherla
The Annals of Thoracic Surgery. 2025-04-01 - Denial for Advanced Heart Failure Therapies Due to Psychosocial Stressors: Who Comes Back?Kayla Buttafuoco, Daniel Daunis, Tandra Carter, Jolaunda Hoye, Maura Webb
Journal of Cardiac Failure. 2025-03-01 - 3 citationsCardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa, Theodore P Abraham, Douglas Marshall Brinkley
European Heart Journal. 2024-11-08
Authored Content
- Heart Failure Self-Assessment Program: Rejection (chapter)June 2020
Press Mentions
Using Pulmonary Artery Pressure Monitoring to Manage Obese HF Patients Leads to Strong OutcomesNovember 3rd, 2021
Committees
- Education Committee, Heart Failure Society of America 2017 - 2019
Professional Memberships
- Member
- Heart Failure Society of AmericaMember
- International Society for Heart and Lung TransplantationMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
